POP-OUT | CLOSE
 
 
2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
 
SCK is found in 2 entries
SCK
  •   Chemical Component Summary   Hide
    Name 2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM)
    Identifiers trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium
    Synonyms SUCCINYLDICHOLINE
    Formula C14 H30 N2 O4
    Molecular Weight 290.40 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key AXOIZCJOOAYSMI-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00202   (Stereoisomeric match)
    Name Succinylcholine
    Groups approved
    Description A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
    Synonyms
    • 2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium)
    • Dicholine succinate
    • Succinic acid, diester with choline
    • Succinocholine
    • Succinoylcholine
    • Succinylbischoline
    • Succinylcholine
    • Succinyldicholine
    • Suxamethonium
    [more]
    Salts Succinylcholine Chloride
    Brand names
    • Anectine
    • Quelicin
    • Scoline
    • Sucostrin
    Affected organism Humans and other mammals
    Indication Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)
    Pharmacology Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine is a depolarizing skeletal muscle relaxant. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the receptor site. Succinylcholine has no direct action on the uterus or other smooth muscle structures.
    Mechanism of action The mechanism of action of Succinylcholine involves what appears to be a "persistent" depolarization of the neuromuscular junction. This depolarization is caused by Succinylcholine mimicking the effect of acetylcholine but without being rapidly hydrolysed by acetylcholinesterase. This depolarization leads to desensitization.
    Route of administration Intravenous
    Categories
    • Neuromuscular Depolarizing Agents
    • Muscle relaxant, Skeletal
    ATC-Code M03AB01
    AHFS-Code 12:20.00
    CAS number 306-40-1
    Targets
    Name Sequence search Pharmacological action Actions
    Muscarinic acetylcholine receptor M3   Search  unknown agonist
    Muscarinic acetylcholine receptor M3   Search  unknown agonist
    Muscarinic acetylcholine receptor M1   Search  yes agonist
    Muscarinic acetylcholine receptor M1   Search  yes agonist
    Neuronal acetylcholine receptor subunit alpha-10   Search  yes agonist
    [more]
     
Ligand Image